Emily Zhen
About Emily Zhen
Emily Zhen is a Principal at Zeal Capital Partners with extensive experience in investment banking, healthcare, and business development.
Current Role at Zeal Capital Partners
Emily Zhen currently serves as a Principal at Zeal Capital Partners, a role she began in 2023. In her position, she focuses on identifying and supporting investment opportunities, particularly at Seed and Series A stages. Her work at Zeal Capital Partners involves strategic oversight and guidance to healthcare, fintech, and the future of work and learning sectors.
Previous Experience in Investment
From 2020 to 2023, Emily Zhen worked as an Investor at New Enterprise Associates (NEA) in Menlo Park, California. During this period, she was also an investor in several companies including Slope, Spiras Health, Waymark, Vori Health, and Curana Health. Her role involved participating in investment decisions, providing strategic advice, and serving as a Board Observer for some of these organizations.
Background in Investment Banking and Consulting
Emily Zhen has a solid background in investment banking, having worked at Goldman Sachs in New York City from 2018 to 2020 and from 2016 to 2017. Before joining Goldman Sachs, she served as a Consultant at PwC in Hong Kong in 2014. Her experience in these roles included conducting financial analyses, strategic planning, and improving performance outcomes for clients.
Educational Qualifications
Emily Zhen has an impressive educational background. She holds a Master of Business Administration (MBA) from The Wharton School. Additionally, she earned a Bachelor of Arts (B.A.) in Biology/Biological Sciences, General, and a Bachelor of Science (B.S.) in Economics, Finance, and Healthcare Policy from the University of Pennsylvania. This diverse academic foundation supports her expertise across biology, finance, and healthcare policy.
Board Roles and Writing Contributions
Emily serves as a Board Director for ViuHealth and Auxa Health, offering her strategic insights to their operations and growth strategies. Her writing contributions include articles on health equity trends and investment strategies, reflecting her deep engagement with current issues in healthcare and finance. Additionally, she has been involved in investment decisions for companies such as Seven Starling and Jiseki.